chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine approximately 3:15pm on 4/19/2019 and was extremely tired at dinner at 7:30pm with left arm sore, Woke up next day at 7:30am 4/20/2019 with headache, extremely sore arm, shivering, muscle aches on entire body, cough, and difficulty breathing. I could not perform any activities of daily living and went back to bed. Slept all day, woke for 2 hours and went back to bed until 7:00am the next morning. Felt better this morning 4/21 but not 100% until morning of 4/22.
It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Text: Is this correct? Yes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Text: Is this correct? Yes) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Text: Is this correct? Yes). At the time of the report, VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Text: Is this correct? Yes) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
ON 10.6.23 I RECIEVED THE COVID-19 BOOSTER, ON 10.7.23 I WOKE WITH JOINT PAIN THAT GOT PROGRESSIVLY WORSE AS THE DAY WENT ON, I HAD DIFFICULTY WALKING ALONE ON SATURDAY EVENING. I HAD SKULL PAIN, AND I ALSO EXPERIENCED ELECTRIC/TINGLING IN MY LEFT BREAST UP TO MY NECK OFF/ON SATURDAY EVENING.  ON 10.8.23 I STARTED WITH DIARRHEA AND VOMITING, THAT LASTED MOST OF THE DAY. I CALLED MY PCP WHO GAVE ME ZOFRAN, IT HELPED AFTER A FEW HOURS. I DID NOT WORK ON MONDAY AS I WAS STILL RECOVERING.
24 hours after administration of Varivax in left arm, 4.5cm erythematous raised oval area minimally tender, non-fluctuant.  Examined 48 hours after administration.
Loss my sense of smell and taste; three days got sick with cold - still have stuffy nose; three days I felt dizzy and I wake up to go to the restroom and I feel like  I will fall.  I treat with fluids .And I have an antiobiotics from appt with doctor. I had a little cough but not a bad one. My head hurts a little but not that much.   COVID test on the  13th or so of January. Results on 16th - positive. They told me not to go to work.  On the 30th I went to work.
Patient received flu vaccine at school flu clinic 11/9/16. Several hours later developed 103 degree F fever, HR of 137 and rash on chest. Mother called to report this the following day 11/10/16. Mother states taking to PMD.
Chicken pox disease - onset of fever 2/25/08 with fever bumps spreading onto tummy, back and legs
9:30pm - Baseball size swelling. 7/10 pain. Unable to elevate arm above waist. Applied ice and took 400mg naprox sodium. 10:00pm - Began to feel burning sensation in skin across ENTIRE body. No difficulty breathing. Self administered 50mg Benadryl. 11:00pm - Dizziness. Temp normal. Extreme malaise. Swollen area in Left delt extremely hard to touch and white in color. Pain continues 8/10. 1am - Pain unchanged. No fever. Skin still burning and shivering. Administer 1g Tylenol. 7am - No sleep. Continue w/ ice. Naprox 400mg. Pain unchanged. 5pm - entire day in bed with severe flu-like (not just virus like) symptoms. Swelling is less localized and spreading in arm although less severe. Continue w/ ice and Tylenol. 8pm: Sleep for 12 hours. 8am: Swelling reduced by 50%. No fever. Pain 5/10. Color returning to area. Headache. 12pm: unchanged. continue ice + rotate naprox w/ Tylenol q3hrs. No signs if cellulitis.
Rash at injection site, area is raised, small bumps. No pain or itching. Pt was fine on 7/12/10, diagnosed as delayed hypersensitivity.
I had a lump appear on my right collar bone, same reaction as the first dose. I commutated with my Dr. regarding this issue and they believe it's vaccine related. This was smaller and has gone away.
Headache, Myalgia, Fever, CHILLS,FATIGUE Narrative: SX RESOLVED WITHING 24 HOURS
On 1/12/00, the pt received his vaccine and on the 13th he experienced a local reaction. The 14th he was rechecked. He has been afebrile and complains only if you push right on the area. He has a fairly impressive flat, brawny, pink 8 cm reaction with a little bruising. His range of motion is normal and there is no evidence at this time of cellulitis.
This spontaneous report as received from a physician refers to unspecified patients of unknown age and unknown gender. On an unknown date, the unspecified patients were vaccinated with unspecified doses of PEDVAXHIB (Lot No. K004541 and expiration date: 04-DEC-2016) (dose and route were not provided) on unspecified dates. No adverse effects were reported. The information stated that the PEDVAXHIB administered was improperly stored. This is one of several reports received from the same source. Additional information has been requested.
Went to. the urgent care on 3/20 after waking up two days after getting first COVID-19 Moderna vaccine  Had sever ear pain and sore throat. Dr. looked at it and thought it was ear infection snd prescO
Initial health care professional report received on 12 Jan 2010: This patient was vaccinated with S-OIV Fluvirin; batch number unknown) on 06 Jan 2010 at 3:40 PM. After 10 minutes of vaccine administration, the patient experienced breathing difficulty, throat constriction and hypotension. As corrective measure, treatment with epinephrine was given. The patient's breathing improved and blood pressure increased to 152/70 (units not provided). The patient was taken to the local emergency room for follow-up but was not hospitalized. No outcome was provided for hypotension and throat constriction.
Itchy; 101.5 degree fever; Chills; Skin rash all over my torso; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included slight allergy possibly to a liquid laundry detergent containing perfume. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 09:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 09May2021, in the evening, the patient experienced fever, chills and skin rash all over torso. On 11May2021, after 2 days, fever subsided and skin rash faded a little, but became very itchy. Every once a while it became incredibly itchy which was impossible to resist and he started to scratch himself everywhere on his torso. The patient further stated that, after 10 - 15 minutes, the itch goes away but usually comes back within few hours. On 09May2021, the patient underwent body temperature test and the result was 101.5 degrees (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever was resolved on 11May2021, after the duration of 2 days. The clinical outcome of the events chills and itchy were not resolved; while that of the event skin rash all over torso was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Itching of the arm where the vaccine had been given and at 4:00 PM when I saw her she had a fine papular rash up and down the arm. No problems breathing or anything else.
Post vaccination the patient developed atrophy at the injection site. Information received 05/12/2000 states the patient's parents noticed a smooth indentation in the outer right thigh area, at or lateral to the site where the IPV was given. The site never scabbed, and remained red, swollen, blistered and tender.
fatigued; slept for pretty much 13 hours, maybe more than that; slight headache; Nausea; fatigued; slept for pretty much 13 hours, maybe more than that; chills; feels like he's burning up but don't have a fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, and CHILLS in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT. At the time of the report, SOMNOLENCE (fatigued), HEADACHE, NAUSEA, FATIGUE, CHILLS, and FEELING HOT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included Tylenol.
Severe back and neck pain. Severe pain in several fingers and now also in toes. Went to Chiropractor, Orthopedic and Physical Therapy. The follow up states back and neck pain. Severe pain in several fingers like arthritis.
4/10/21  1-2 sores on her tongue 3-4 am w/fever  102.5, headache. Took tylenol and ibuprofen. burning , watery eyes.  10 am 101.7 continued for the day. Temp 100.3-101. 4/11/21 5-6 spots on tongue, fever 100-101.5  headache less severe continued OTC meds all day 4/12/21 10 spots on tongue, fever 100.8 continued Tylenol through the day, ibuprofen only once. Went to the dentist prescibed chlorhex glu .12% solution to prevent infection . 20% benzocaine OTC for pain. Fever down to 99.0-100.8 today 4/13/21 sores stopped multiplying but still large and painful.  Fever 99.6 highest this day. 4/14/21 sores still there but no new ones.  Feels feverish but temp down to 98.
Her lips had abnormal swelling; This spontaneous case was reported by an other health care professional and describes the occurrence of LIP SWELLING (Her lips had abnormal swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced LIP SWELLING (Her lips had abnormal swelling). At the time of the report, LIP SWELLING (Her lips had abnormal swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication were not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  The patient received Kysse product in lips on 05/Apr/2022. The next day 06/Apr/2022 she received the Moderna booster. Her lips had abnormal swelling. This was her 4th shot and she has not had filler injected in her lips in a few years.
13 YO Female received a second dose of Pfizer 5-11yo instead of appropriate does of 12 and older.
Patient fainted about 10 minutes post vaccine administration. He sat on the bench while his mother held his head upright. He laid on the bench briefly. Patient fully recovered and left the pharmacy without needing medical attention.
Recipient reports feeling bad all over started immediately, shaking but waited in his car in the parking lot after the 15 minute waiting period. Reported back into the vaccination site approx 45 minutes after his injection. Elevated BP 150/105, few minutes later was 170/110 hr 125 rr 20 skin clammy at intervals. Glucose 148 per his report from his insulin pump.  No hypertension history or meds per his report.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: en6206), in right arm, on 08Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 15Oct2021 as dose 3 (booster), single (Lot number: ff2590) at the age of 42 years, in right arm for covid-19 immunization. The patient had no relevant medical history and no known allergies. There were no concomitant medications; also reported as no other medication in 2weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23May2022) positive, notes: Rebound Covid positive test on day 8 after stopping Paxlovid 5 day treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started on 11May2022 and stopped on 15May2022. Clinical course was reported as, Symptoms reoccurred on 23May2022 and tested positive again on 22May2022. Rebound Covid positive test on day 8 after stopping Paxlovid 5 day treatment. No treatment received for symptoms and patient was recovering from symptoms.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
At 20 minutes s/p vaccination deltoid became extremely sore . At 2 hours s/p vaccination i became feverish. At 10 hours s/p vaccination I became nauseous and developed a severe headache.
I have experienced pain at the injection site since April 4, 2021. I have used ice, ibuprofen, rested it, etc.  I can not comfortably sleep on  that side and the pain  radiates down the arm. I have never had a reaction to any injection before. The pain has had an adverse effect on my ability to sleep well and  pain continues throughout the day. It is a constant aching pain - similar to that of a muscular "tear" + nerve pain.
Information has been received from a consumer via Pfizer referring to a patient of unknown age or gender. The patient pertinent medical history and concurrent condition were not reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (lot #, expiration date, dose and frequency were unknown). On an unknown date the patient who received the pneumococcal conj vaccine (unspecified) after being vaccinated with PNEUMOVAX 23 experienced an Arthus reaction (reported as "an Arthus reaction"). The outcome of the event was unknown. Additional information has been requested.
Pt received vaccine in L SQ arm.  The following day-pt arm swelled up turned red and pt had fever of 101.0.
PATIENT REPORTS THAT  WITHIN 2 DAYS OF RECEIVING FIRST DOSE OF PFIZER COVID-19 VACCINE HE STARTED WITH DAILY HEADACHES, NOSEBLEEDS, BILATERAL EAR PAIN AND RUNNY NOSE.
Vaccine exposure during breastfeeding; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPOSURE VIA BREAST MILK (Vaccine exposure during breastfeeding) in a 34-year-old female adult exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) , while the mother received the product for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the mother received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the adult was diagnosed with EXPOSURE VIA BREAST MILK (Vaccine exposure during breastfeeding). The Adult was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The treatment medication was included Prenatal vitamins.; Sender's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
This spontaneous report was received from an other health professional (licensed practical nurse) refers to a patient of unknown demographics. On 04-FEB-2015 the patient was vaccinated with VARIVAX (Merck) (lot # J001177, expiry date: 31-JAN-2015). The patient experienced expired product administered as he/she was mistakenly vaccinated with an expired dose of VARIVAX (Merck). No adverse effects were reported. No product quality complaint (PQC) was involved. Outcome of the event expired product administered was unknown. Reporter considered the event expired product administered to be not related to VARIVAX (Merck). Additional information has been requested.
feeling tired and wiped out; uncontrolled crying; high anxiety; boost of energy; heart was racing; she is not sleeping; have taken FLULAVAL QIV whilst on prednisone; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 63-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis and prednisone for product used for unknown indication.   Concurrent medical conditions included ulcerative colitis and asthma.   On 23rd November 2021 07:45, the patient received FluLaval Quadrivalent 2021-2022 season. On 23rd November 2021, the patient started Flulaval Tetra Pre-Filled Syringe Device. In November 2021, the patient started prednisone 60 mg at an unknown frequency. On 23rd November 2021, the dose was changed to 40 mg at an unknown frequency. On 23rd November 2021, less than an hour after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced tiredness, crying uncontrollable, anxiety, energy increased, heart racing, insomnia and off label use. The dose of prednisone was decreased. On an unknown date, the outcome of the tiredness, crying uncontrollable, anxiety, energy increased, heart racing and insomnia were recovered/resolved and the outcome of the off label use was unknown.   It was unknown if the reporter considered the tiredness, crying uncontrollable, anxiety, energy increased, heart racing and insomnia to be related to FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of FluLaval Quadrivalent 2021-2022 season at her physician office this (day of reporting) morning at 7.45am and within an hour she experienced some side effects like boost of energy, heart was racing, high anxiety, uncontrolled crying, and is now feeling tired and wiped out that lasted about 1.5 hours. The patient was currently taking Prednisone and was on day 4 of a tapering regimen. The reporter also stated that she had been taking Prednisone 60mg for 3 days and today (day of reporting) she took 40mg.  The patient was not sleeping due to taking Prednisone. The reporter stated that she did contact her clinic and spoke to the nurse. The reporter would like to know if she should not have taken FLULAVAL QIV whilst on prednisone.  The reporter was given medical disclaimer and referred to HCP. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. It was unknown if the reporter considered the tiredness, crying uncontrollable, anxiety, energy increased, heart racing to be related to prednisone. The reporter considered insomnia to be related to prednisone.
PATIENT DISCLOSED AFTER VACCINATION A FEAR OF NEEDLES, FAINTED AT CLINIC, HIT HEAD ON FLOOR, CUT ABOVE EYE AND BROKEN TOOTH.
Patient states he felt "strange" after rcving hpv vaccine, got up to go to the restroom, fell to the floor, hit his head on the floor, stiffened, eyes rolled back in his head, LOC at least 10 seconds, then very groggy when he came to. upon leaving the office 30 minutes after getting vaccine, was talking and smiling with a large knot on his head.
Very soon after 2nd dose; chills, nausea, headache, weakness.  Long term ongoing; fluttering heart, pounding heart, orientation problems, head aches, and decreased aerobic capacity.
I broke out into a rash; Rash on my neck, my left arm like where you would bend the elbow and then all my face, it is starting on my face; I broke out into a rash; Rash on my neck, my left arm like where you would bend the elbow and then all my face, it is starting on my face; I broke out into a rash; Rash on my neck, my left arm like where you would bend the elbow and then all my face, it is starting on my face; My eyes were puffy; This is a spontaneous report from a contactable consumer (patient). A 53-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: FA6780, Expiry Date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 19Jul2021 (at the age of 53-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. The patient relevant medical history was none. The patient's concomitant medications were not reported. The patient reported that, I broke out into a rash; rash on my neck, my left arm like where you would bend the elbow and then all my face, it is starting on my face and my eyes were puffy all on 20Jul2021. Consumer stated that, "I was talking to my doctor and after receiving a first vaccine dose of Pfizer, they suggested that I call because I broke out into a rash. So, I woke up the next morning and my eyes were puffy and since then, I developed a rash on my neck, my left arm like where you would bend the elbow and then all my face, it is starting on my face now." Consumer stated, "Not on the elbow but like on the part where you would bend your arm, "I was taking Benadryl, and was asking was that okay for me to take". Consumer further stated, "Okay, I took a little Benadryl that was it." Outcome of the events were unknown.  Follow-up attempts are completed. No further information is expected.